Loading page...
Find the funds that fit what you’re building. European venture capital, organised by stage, sector and geography.
Find investors ↓
Connect with your free EUACC account.
Start with stage and geography. Open a profile to check the fund’s thesis before you reach out.
Fund size is the whole fund, not the cheque you can raise. EIF backing does not mean a fund is currently accepting pitches. Unknown stages stay in “All funds”.
Alven is an independent early-stage venture capital firm based in Paris, investing at the seed and Series A stages across European technology. Its fifth fund, Fund V, is around EUR 300M, and the firm backs companies in general tech and fintech, including B2B software, marketplaces and consumer finance. Alven is backed by the EIF.
Keensight Capital is a Paris-based growth-equity firm investing in profitable, high-growth technology and healthcare companies across Europe. Its Nova VI fund closed at around EUR 2.3 billion and is backed by the European Tech Champions Initiative (ETCI). Founded in 1998, Keensight typically backs companies with revenues between EUR 10 million and EUR 400 million.
Omnes Real Tech 2 is a deeptech fund managed by Omnes Capital, the Paris-based private equity firm, targeting Series A and Series B rounds. It backs European technology and climate-focused scale-ups and is supported by the EIF and the InvestEU programme, having reached a EUR 112M first close in 2025. It was the first fund in Europe to draw on the EU's InvestEU defence mandate.
Partech Growth III is a growth-stage fund managed by Partech in Paris, investing across seed, Series A and growth rounds into European technology companies. The fund is around EUR 300M in size and is backed by the European Investment Fund. Partech is a global investor with offices in Paris, Berlin, San Francisco and other hubs.
Quantonation is an early-stage deep tech fund based in Paris, investing at seed and Series A into quantum technologies and deep-physics startups. This vehicle is its second flagship fund, which closed above target at around EUR 220M and is backed by the EIF (a EUR 30M commitment). Portfolio companies include Pasqal, Multiverse Computing and Qubit Pharmaceuticals.
Sofinnova Partners is a life sciences venture capital firm based in Paris, investing at Series A and Series B in healthcare, biotech and medtech. Its Capital XI fund closed at around EUR 650M in 2025 to back 50 to 60 early-stage companies across Europe and North America, and the firm is backed by the EIF.
Alven Capital V is a fund managed by Alven, an independent early-stage venture capital firm based in Paris. Alven backs European technology startups at seed and Series A across B2B software, marketplaces, AI and fintech, typically writing first cheques of EUR 0.5-5M. The manager is classified by the EIF under the ICT sector and is known for early backing of Qonto, Dataiku and Algolia.
Seed fund focused exclusively on microbiology and infectious diseases, managed by Auriga Partners in Paris. The EUR 43m fund is backed by the French government (FNA), the EIF and industry partners including Pfizer, Sanofi-Pasteur and MSD. Part of a firm that has raised over EUR 390m across five funds.
Seed-stage cleantech fund raised by Demeter Partners (now rebranded as Demea Sustainable Investment), closed at €45 million in October 2012. Backs very early-stage companies developing innovative technologies in eco-energy and eco-industry — water, air, and waste treatment — primarily in France, Germany, and Spain. Backed by Suez Environnement, Air Liquide, Bpifrance's National Seed Fund, and the European Investment Fund.
Early-stage venture fund raised by Paris-based Elaia Partners in 2012, investing in European software and technology companies. The manager has since grown to approximately €850 million in total AUM across successor funds, with a portfolio including Criteo, Mirakl, and Alice & Bob.
Ecotechnology seed fund managed by Emertec Gestion in Grenoble. Raised EUR 50m (against a EUR 60m target) to back 15-20 early-stage startups in energy, green chemistry and the environment, investing up to EUR 5m per company. Backed by Bpifrance (EUR 23m) and the EIF (EUR 15m).
Expansion SLP is a deep-tech fund managed by Expansion Ventures, based in Paris with offices in Luxembourg and Stockholm. It invests from pre-seed to Series B in sustainable aerospace and defence, including space technologies and sustainable aviation. A first tranche of EUR 137 million has been closed for the fund.
Fonds Entrepreneurs Occitanie Ouest is a EUR 15M early-stage fund managed by M Capital Partners, backed by the European Investment Fund and the Occitanie region. It supports innovative SMEs from proof of concept through early commercial growth, writing tickets of EUR 150k-1.5M. Portfolio companies span fintech, edtech, agri-tech and aerospace.
Sista Fund I is a French venture fund (FPCI) managed by Sunshine SAS in Paris, founded by Tatiana Jama out of the Sista NGO to close the funding gap for women entrepreneurs. It backs pre-seed to Series A tech companies where women hold at least 30 percent of founder shares, across health tech, sustainability, deep tech and inclusive fintech, and is backed by the EIF with a EUR 30M commitment.
French venture fund (FCPR Galileo III) managed by Galileo Partners, a Paris-based private equity firm founded in 1989. Galileo Partners manages €250M in capital and focuses on technology — software, internet, electronics, semiconductors, telecoms and medical tech. The firm has completed 97 investments with 7 IPOs and 34 acquisitions, including Genesys, Talend and Atari.
First seed-stage venture fund managed by Go Capital, a Rennes-based firm founded in 2003 and the leading early-stage investor in Western France (Brittany, Pays de la Loire, Normandy). Closed at €57 million with 25 portfolio companies in healthcare, digital, energy transition, and industrial sectors.
GO Capital Amorcage II is an early-stage (seed) venture capital fund managed by GO Capital SAS, an independent firm based in Rennes that has backed regional technology and healthcare companies across western France since 2003. The fund held a roughly EUR 70M close against an EUR 80M target and invests in digital and life-science startups. GO Capital manages close to EUR 400M across its vehicles.
IMPACT Growth V is a social impact fund managed by IMPACT Partners, a Paris-based investment firm and one of Europe's pioneers in social impact investing, with around EUR 340M under management. The fund provides growth and expansion capital to companies that combine financial returns with measurable social impact across Europe.
Third fund from Impact Partners, a Paris PE firm founded in 2008 supporting French SMEs through development capital, venture and buyout. The firm manages EUR 340m in total AUM across more than 180 portfolio companies in growth-phase businesses across all sectors.
INN'VEST PME Occitanie Est is a EUR 15M seed and early-stage fund managed by IRDI Capital Investissement, backed by the European Investment Fund and the Occitanie/Pyrenees-Mediterranee Region via the EUR 43M FOSTER TPE-PME fund of funds. It provides equity to innovative SMEs in eastern Occitanie at tickets of EUR 200k-2.25M, covering digital, healthcare, eco-industries and agro-technology sectors.
ISAI Expansion III is a tech-focused expansion and growth fund managed by ISAI Gestion in Paris. The fund backs profitable technology SMEs, taking minority or majority stakes in France, Southern Europe, Switzerland and the Benelux via growth buyouts and tech growth deals, with tickets in the EUR 10-50M range. It is backed by the European Investment Fund, Bpifrance and Eurazeo.
Dedicated to investments in southern France across cleantech, sustainability, health, life sciences, and digital sectors at expansion stage.
Regional co-investment vehicle created under the EU's JEREMIE initiative for Languedoc-Roussillon, co-funded by the regional authority and the European Regional Development Fund (ERDF) via a €30 million EIF-managed holding fund. Managed by SORIDEC, it backed 30 early-stage technology SMEs in health, IT, robotics, and environmental sectors. Investment period closed December 2015.
First Kurma Diagnostics (KDx) fund from Kurma Partners, an Eurazeo subsidiary in Paris. The EUR 35m fund backs companies developing disruptive diagnostic solutions that reach commercial revenue within 3-5 years. Kurma later closed Kurma Diagnostics 2 (KDx2) at EUR 83m in 2021; total Kurma AUM now exceeds EUR 1bn.
A reviewed startup profile, a website backlink and a place for investors and consortium partners to discover your work.
